The weekly litigation news digest is live. Subscribe now

IP Verse

Syringe - EP3858405

The patent EP3858405 was granted to Novartis on Apr 5, 2023. The application was filed on May 30, 2013 under application number EP21164847A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3858405

NOVARTIS
Application Number
EP21164847A
Filing Date
May 30, 2013
Status
Granted And Under Opposition
Mar 3, 2023
Publication Date
Apr 5, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSJan 5, 2024ELKINGTON AND FIFEWITHDRAWN
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBJun 29, 2023KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBWITHDRAWN

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2005121176
OPPOSITIONEP3536310
OPPOSITIONJP2004313369
OPPOSITIONUS2007250017
OPPOSITIONUS2010100054
OPPOSITIONUS4946441
OPPOSITIONUS7060269
OPPOSITIONUS7678078
OPPOSITIONWO2011006877
SEARCHUS2001056264
SEARCHUS4946441
SEARCHUS8075535
SEARCHWO2011006877
SEARCHWO2011122574

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents